Impaired SNF2L Chromatin Remodeling Prolongs Accessibility at Promoters Enriched for Fos/Jun Binding Sites and Delays Granule Neuron Differentiation.
ATAC-seq
ISWI chromatin remodeler
SMARCA1
Snf2L
cerebellar granule neuron progenitors
chromatin accessibility
Journal
Frontiers in molecular neuroscience
ISSN: 1662-5099
Titre abrégé: Front Mol Neurosci
Pays: Switzerland
ID NLM: 101477914
Informations de publication
Date de publication:
2021
2021
Historique:
received:
13
03
2021
accepted:
10
06
2021
entrez:
23
7
2021
pubmed:
24
7
2021
medline:
24
7
2021
Statut:
epublish
Résumé
Chromatin remodeling proteins utilize the energy from ATP hydrolysis to mobilize nucleosomes often creating accessibility for transcription factors within gene regulatory elements. Aberrant chromatin remodeling has diverse effects on neuroprogenitor homeostasis altering progenitor competence, proliferation, survival, or cell fate. Previous work has shown that inactivation of the
Identifiants
pubmed: 34295220
doi: 10.3389/fnmol.2021.680280
pmc: PMC8290069
doi:
Types de publication
Journal Article
Langues
eng
Pagination
680280Informations de copyright
Copyright © 2021 Goodwin, Zapata, Timpano, Marenger and Picketts.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
EMBO J. 2002 May 1;21(9):2231-41
pubmed: 11980720
Science. 2002 Jul 19;297(5580):365-9
pubmed: 12130776
Nat Struct Mol Biol. 2014 Jan;21(1):73-81
pubmed: 24317492
BMC Genomics. 2018 Mar 1;19(1):169
pubmed: 29490630
Mol Cell Biol. 2012 Jul;32(13):2359-71
pubmed: 22508985
Neuron. 2005 Oct 6;48(1):17-24
pubmed: 16202705
Front Genet. 2020 Aug 11;11:885
pubmed: 32849845
PLoS One. 2013 Nov 26;8(11):e81769
pubmed: 24303070
EMBO J. 2011 May 4;30(9):1766-77
pubmed: 21448136
Endocrinol Metab Clin North Am. 2017 Mar;46(1):51-62
pubmed: 28131136
Front Mol Neurosci. 2018 Aug 03;11:252
pubmed: 30123105
Nucleic Acids Res. 2016 Jul 8;44(W1):W160-5
pubmed: 27079975
PLoS Genet. 2016 Apr 05;12(4):e1005969
pubmed: 27046080
Nature. 2012 Jan 04;481(7381):389-93
pubmed: 22217937
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
J Vis Exp. 2009 Jan 16;(23):
pubmed: 19229177
Mol Cell Neurosci. 2018 Mar;87:55-64
pubmed: 29249292
PLoS Genet. 2015 Oct 06;11(10):e1005555
pubmed: 26440048
Int J Mol Med. 2018 Aug;42(2):713-725
pubmed: 29786110
Nature. 1997 Aug 7;388(6642):598-602
pubmed: 9252192
Front Cell Neurosci. 2020 Sep 04;14:552213
pubmed: 33088261
FEBS Lett. 2002 Sep 25;528(1-3):241-5
pubmed: 12297313
Mol Cell Biol. 2011 Aug;31(16):3326-38
pubmed: 21690300
Nat Neurosci. 2013 Dec;16(12):1737-44
pubmed: 24141309
Genes Dev. 1999 Jul 1;13(13):1647-52
pubmed: 10398678
Nat Rev Mol Cell Biol. 2017 Jul;18(7):407-422
pubmed: 28512350
Cell Tissue Res. 2009 Sep;337(3):407-28
pubmed: 19609565
Neuron. 2005 Jul 21;47(2):201-13
pubmed: 16039563
Neuron. 1996 Sep;17(3):389-99
pubmed: 8816703
Neuron. 1999 Jan;22(1):103-14
pubmed: 10027293
Curr Vasc Pharmacol. 2007 Jan;5(1):45-52
pubmed: 17266612
Dev Cell. 2019 Jan 28;48(2):184-199.e5
pubmed: 30695697
Annu Rev Neurosci. 1995;18:385-408
pubmed: 7605067
Development. 2005 May;132(10):2425-39
pubmed: 15843415
Nature. 1997 Nov 13;390(6656):169-72
pubmed: 9367153
EMBO J. 2001 Sep 3;20(17):4892-900
pubmed: 11532953
PLoS Genet. 2008 Oct;4(10):e1000241
pubmed: 18974875
Genes Dev. 2011 Feb 1;25(3):275-86
pubmed: 21289071
Curr Protoc Mol Biol. 2015 Jan 05;109:21.29.1-21.29.9
pubmed: 25559105
G3 (Bethesda). 2012 Sep;2(9):987-1002
pubmed: 22973536
Curr Biol. 1999 Apr 22;9(8):445-8
pubmed: 10226030
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14097-102
pubmed: 14617767
Mol Cell Biol. 2015 Jan;35(1):224-37
pubmed: 25348714
Front Neurosci. 2018 Apr 09;12:226
pubmed: 29686607
Cell. 1999 Jun 25;97(7):843-52
pubmed: 10399913
Nat Methods. 2013 Dec;10(12):1213-8
pubmed: 24097267
PLoS Genet. 2016 Mar 28;12(3):e1005940
pubmed: 27019336
Science. 1998 Dec 4;282(5395):1900-4
pubmed: 9836642
Mol Cell. 1999 Feb;3(2):239-45
pubmed: 10078206
Neuroscience. 1998 Mar;83(2):321-34
pubmed: 9460743
Dev Dyn. 2019 Jul;248(7):506-513
pubmed: 31131952
Mol Cell. 2010 May 28;38(4):576-89
pubmed: 20513432
Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4661-4670
pubmed: 30765517
J Biol Chem. 2004 May 7;279(19):20369-77
pubmed: 14990586
BMC Bioinformatics. 2010 May 11;11:237
pubmed: 20459804
Development. 1999 Jun;126(14):3089-100
pubmed: 10375501
Dev Cell. 2012 Apr 17;22(4):871-8
pubmed: 22516202
Development. 2012 May;139(10):1724-33
pubmed: 22461560
Mol Cell. 2015 Mar 5;57(5):850-859
pubmed: 25684208
Nat Commun. 2020 May 1;11(1):2138
pubmed: 32358570
Stem Cell Reports. 2017 Jul 11;9(1):23-31
pubmed: 28579392
Hum Mol Genet. 2005 Feb 15;14(4):513-24
pubmed: 15640247
Front Cell Dev Biol. 2016 Jun 08;4:53
pubmed: 27376062
Nat Neurosci. 2017 Oct;20(10):1361-1370
pubmed: 28805814
EMBO Rep. 2017 Oct;18(10):1697-1706
pubmed: 28801535
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Neural Dev. 2019 Feb 14;14(1):4
pubmed: 30764875
Cell. 1997 Jul 11;90(1):145-55
pubmed: 9230310
Wellcome Open Res. 2016 Nov 15;1:14
pubmed: 27918597
Brief Bioinform. 2013 Mar;14(2):178-92
pubmed: 22517427
Cell. 1995 Dec 15;83(6):1011-20
pubmed: 8521501
Elife. 2016 Nov 08;5:
pubmed: 27823583
Front Mol Neurosci. 2019 Oct 17;12:243
pubmed: 31680852
Dev Biol. 2021 Jun;474:37-47
pubmed: 33571486
Nat Commun. 2014 Jun 20;5:4181
pubmed: 24946904